Cross‐sectional analysis of germline <i>BRCA</i>1 and <i>BRCA</i>2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer

Kokichi Sugano(Tochigi Cancer Center), Yoshio Miki(Japanese Foundation For Cancer Research), Hiroko Komatsu(Japanese Red Cross Kyushu International College of Nursing), Yasuo Hirai(The Cancer Institute Hospital), Masami Arai(Juntendo University), Naoko Arimori(St. Luke's International Hospital), Hiromitsu Jinno(Keio University), Noriko Matoba(St. Luke's International Hospital), Shino Umezawa(National Cancer Center), Hiroshi Yagata(Breast Center), Nobuhisa Gondo(Shimizu (Japan)), Shin Takayama(Tohoku University), Megumi Ubukata(Cancer Clinic), Tetsuro Kodama, Hiroyuki Kamata(Jichi Medical University), Takayuki Kinoshita(Tokyo National Hospital), Tadashi Ikeda(Keio University), Akira Hirasawa(Okayama University), Kumiko Yazaki(Keio University Hospital), Seigo Nakamura(SHOWA Medical University), Masaki Kitajima(Keio University Hospital), Jiro Ando(Jichi Medical University), Yuko Takeda(Kanazawa University), Shiro Yokoyama(Shimizu (Japan)), Teruhiko Yoshida(National Cancer Centre Japan), Isao Sekiguchi, Ryuichiro Tsunematsu, Fujio Kasumi(Japanese Foundation For Cancer Research), Daisuke Aoki(International University of Health and Welfare), Masako Izumi(National Cancer Center), Takashi Fukutomi
Cancer Science
October 1, 2008
Cited by 105


Related Papers